Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes

被引：3

作者：

Harding, SA ^{[1
]}

Boon, NA ^{[1
]}

Flapan, AD ^{[1
]}

机构：

[1] Royal Infirm Edinburgh NHS Trust, Dept Cardiol, Edinburgh EH3 9YW, Midlothian, Scotland

来源：

关键词：

D O I：

10.1016/S0140-6736(02)09472-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：256 / 257

页数：2

共 5 条

[1] Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes:: a meta-analysis of all major randomised clinical trials
Boersma, E
Harrington, RA
Moliterno, DJ
White, H
Théroux, P
Van de Werf, F
de Torbal, A
Armstrong, PW
Wallentin, LC
Wilcox, RG
Simes, J
Califf, RM
Topol, EJ
Simoons, ML
[J]. LANCET, 2002, 359 (9302) : 189 - 198
[2] A critical appraisal of platelet glycoprotein IIb/IIIa inhibition
Chew, DP
Moliterno, DJ
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (07) : 2028 - 2035
[3] Meta-analysis: Principles and procedures
Egger, M
Smith, GD
Phillips, AN
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7121): : 1533 - 1537
[4] Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
Topol, EJ
Moliterno, DJ
Herrmann, HC
Powers, ER
Grines, CL
Cohen, DJ
Cohen, EA
Bertrand, M
Neumann, FJ
Stone, GW
DiBattiste, PM
Demopoulos, L
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (25) : 1888 - 1894
[5] Yusuf S, 2001, NEW ENGL J MED, V345, P494